Cookie technology helps us bring you the best possible experience when you visit this website. Please let us know if you're happy to accept cookies. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.

en:

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}
      • Atopic Dermatitis Home
      Articles
      Infographics & Posters

      Videos  

      alt

      Duration 6:28

      Dr. Jonathan Silverberg

      Associate Professor George Washington University School of Medicine and Health Sciences

       

      "Upadacitinib in Moderate-to-sever Atopic Dermatitis"

      alt

      Duration 3:11

      Dr. Patrick Gunning

      Professor of Medical Chemistry,

      University of Toronto Missiauga

       

      "JAKs MoA"

      alt

      Duration 6:34

      Dr Diamant Thaçi

      Chairman and Professor, Center for Comprehensive Inflammation Medicine, University of Luebeck

       

      "padacitinib Clinical Benefit-risk Profile in Moderate-to-severe Atopic Dermatitis"

      alt

      Duration 5:02

      Dr. Chich-Ho Hong

      Clinical Assistant Professor University of British Columbia

       

      "Assessment Scales, Treatment Algorithms & Targets"

      alt

      Duration 6:03

      Dr. Matthias Augustin

      Director, Institute for Health Services Research in Dermatology and Nursing ( IVDP),

      Universty Medical Center Hamburg

       

      " Candidates for Systemic Therapy in Atopic Dermatitis "

      alt

      Duration 6:34

      Prof. Melinda Gooderham

      Skin Centre for Dermatology, Ontario, Canada 

       

      "Atopic Dermatitis Current U nmet Needs"

      alt

      Duration 5:02

      Prof. Kilian Eyerich

      Department of Dermatolgy and Allergy, Technical Univeristy Munich, Germany 

       

      " Atopic Dermatitis Complex Pathogenesis"

      alt

      Duration 6:34

      Prof. Melinda Gooderham

      Skin Centre for Dermatology, Ontario, Canada 

       

      "Atopic Dermatitis Burden and Comorbidities"

      alt

      Duration 7:22

      Prof. Melinda Gooderham

      Skin Centre for Dermatology, Ontario, Canada 

      Prof. Alan Irvine 

      Dermatologist in Children's Health Ireland Clinical and research interests in inflammatory and genetic skin disorders 

      "Using Treatment Targets to Meet Patients' Goals in AD Management"

       ABBV-BH-00117-MC  

      alt

      Duration 8:50

      Prof. Jonathan Silverberg

      Associate Professor George Washington University

      School of Medicine and Health Sciences 

       

      "Introducing Minimal Disease Activity Concept in Atopic Dermatitis Management"

       JAKa-BH-00007-MC  

      AbbViePro Logo 2023

      Our therapy areas

      Oncology
      Immunology
      Medical Information
       

      Additional info

      Privacy Notice
      Terms Of Use

       

      For Oman HCPs.

      Department of Pharmacovigilance & Drug information.

      Directorate General of pharmaceutical affairs and Drug control.

      Ministry of Health, Sultanate of Oman

      Phone Nos:: 22357687 / 22357686

      Fax: 22358489

      Email: Pharma-Vigil@moh.gov.om

      Website:www.moh.gov.om

       

       

      This website is intended for Gulf Healthcare Professionals

      AbbVie Biopharmaceuticals GmbH.

       

      Suite 2901, U Bora Tower,Business Bay, Dubai, UAE

      PO Box:: 118052

      OFFICE : +971 4 5506100

      FAX: +971 4 5506101

      Patient Safety is our Priority, we will remain always by your side. For Reporting Adverse events Please Contact.

      PV.MEA@Abbvie.com or Hotline: 00971564135746

      JAKa-BH-00004-MC